Cytiva

Innovation has brought about a diversification of therapeutics molecules. In this discovery interview we will explore what mechanistic modelling is and how you can use it to develop these diverse therapeutics and what challenges this brings to the future of your process development.

Cytiva experts answer your top questions about challenging host cell protein assays to improve risk mitigation.